biotech fireworks Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : biotech fireworks

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (264)	9/16/2002 4:50:42 PM
From: Jibacoa	Read Replies (1) of 7424

BMRN Was up 18.6% in early trading, but it closed up only 14.16%. Volume was above its daily average, after the early news today: ZURICH, Sept 16 (Reuters) - Biotech group BioMarin Pharmaceutical Inc (NasdaqNM:BMRN - News; Zurich:BMRZn.S - News) said on Monday U.S. regulators had granted priority review to the Aldurazyme drug it is developing with Genzyme General Corp (NasdaqNM:GENZ - News). siliconinvestor.com The intra-day H today (5.10)almost matched the intra-day H of July 29 (5.15)Of course there is plenty of resistance above that level.<g> siliconinvestor.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next